OBIO is the official Nasdaq stock exchange ticker symbol used to identify Orchestra BioMed Holdings, Inc., a clinical-stage biomedical company focused on developing high-impact therapeutic solutions for chronic diseases. The enterprise specializes in advancing cardiovascular and therapeutic interventions through unique risk-reward sharing partnerships with major industry leaders rather than traditional standalone commercialization models. Public investors buy and sell shares of OBIO on the open market, tracking its clinical trial progress, regulatory updates, and financial disclosures.